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Abstract
Multiple classes of small RNAs (sRNAs) are expressed in the blood and are involved in the regulation of pivotal cellular
processes. We aimed to elucidate the expression patterns and functional roles of sRNAs in the systemic response to intracranial
aneurysm (IA) rupture. We used next-generation sequencing to analyze the expression of sRNAs in patients in the acute phase of
IA rupture (first 72 h), in the chronic phase (3–15 months), and controls. The patterns of alterations in sRNA expression were
analyzed in the context of clinically relevant information regarding the biological consequences of IA rupture. We identified 542
differentially expressed sRNAs (108 piRNAs, 99 rRNAs, 90 miRNAs, 43 scRNAs, 36 tRNAs, and 32 snoRNAs) among the
studied groups with notable differences in upregulated and downregulated sRNAs between the groups and sRNAs categories.
piRNAs and rRNAs showed a substantial decrease in RNA abundance that was sustained after IA rupture, whereas miRNAs
were largely upregulated. Downregulated sRNA genes included piR-31080, piR-57947, 5S rRNA, LSU-rRNA, and SSU-rRNA
s. Remarkable enrichment in the representation of transcription factor binding sites was revealed in genomic locations of the
regulated sRNA. We found strong overrepresentation of glucocorticoid receptor, retinoid x receptor alpha, and estrogen receptor
alpha binding sites at the locations of downregulated piRNAs, tRNAs, and rRNAs. This report, although preliminary and largely
proof-of-concept, is the first to describe alterations in sRNAs abundance levels in response to IA rupture in humans. The obtained
results indicate novel mechanisms that may constitute another level of control of the inflammatory response.
Key messages
& A total of 542 sRNAs were differentially expressed after aneurysmal SAH comparing with controls
& piRNAs and rRNAs were upregulated and miRNAs were downregulated after IA rupture
& The regulated sRNA showed an enrichment in the representation of some transcription factor binding sites
& piRNAs, tRNAs, and rRNAs showed an overrepresentation for GR, RXRA, and ERALPHA binding sites
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Introduction
Intracranial aneurysm (IA) rupture results in many systemic
effects and strongly influences immune system function. The
molecular mechanisms driving the effects of subarachnoid
hemorrhage (SAH) remain to be elucidated to improve the
management of patients with ruptured IAs. One of the ele-
ments of the systemic effects of IA rupture is changes in the
transcriptome of peripheral blood cells. To date, protein-
coding mRNAs are the RNA class to have been investigated
first and most intensively using microarrays initially and then
next-generation sequencing techniques [1–4]. However, there
is an increasing body of evidence indicating that noncoding
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RNAs (ncRNAs) play a crucial role in many pathological
conditions. According to their length, ncRNAs are divided
into two large categories: long (> 200 bp) and small (< 200
bp) ncRNAs. Small ncRNAs (sncRNAs) are a highly
heterogenic group comprising microRNAs (miRNAs), piwi-
interacting RNAs (piRNAs), short interfering RNAs
(siRNAs), small nucleolar RNAs (snoRNAs), small nuclear
RNAs (snRNAs), promoter-associated small RNAs (PASRs),
transfer RNAs (tRNAs), and ribosomal RNAs (rRNAs). In
general, these RNAs are regulatory molecules influencing
gene transcription, translation, genome integrity preservation,
and epigenetic regulation [5–8].
In our previous studies, we focused on the effects exerted
by IA rupture on the expression of mRNAs and miRNAs in
peripheral blood cells [4, 9]. In this preliminary study, we
investigated changes in the expression of small ncRNAs other
than miRNAs in peripheral blood cells using deep tran-
scriptome sequencing in a single cohort of patients. To assess
time-related changes, patients in the acute (days) and chronic
(months) phases of aSAH were included in the study.
Materials and methods
Patients
The studied cohort was described elsewhere [4]. Briefly, pa-
tients with aneurysmal SAH were prospectively recruited
from consecutive patients of the Departments of Neurology
or Neurosurgery and Neurotraumatology, University
Hospital, Krakow. Two independent patient groups were an-
alyzed: acute (within the first 72 h after IA rupture) and chron-
ic (within 3–15 months after SAH). Control subjects (C) were
recruited from patients in the Department of Neurology who
suffered from headaches. Demographic and risk factor data
were collected using a dedicated questionnaire.
All subjects were Caucasian. Written informed consent
was obtained from all participants (or guardians of partici-
pants) before inclusion in the study. The local ethics commit-
tee approved the study.
Blood collection and RNA extraction
Venous whole blood was collected before neurosurgical inter-
ventions in PAXgene Blood RNA Tubes (PreAnalytiX,
GmbH, Switzerland), mixed, and kept at room temperature
for at least 2 h. The tubes were subsequently frozen and stored
at – 70 °C until further processing. Total RNA was purified
from blood samples using the PAXgene Blood RNA Kit
(PreAnalytiX) according to the manufacturer’s protocol and
was treated with DNase. RNA concentrations were measured
using a NanoDrop ND-1000 Spectrophotometer (NanoDrop
Technologies, Montchanin, DE), and RNA quality was
determined by ChIP-based capillary electrophoresis utilizing
the Agilent RNA 6000 Nano Kit and an Agilent Bioanalyzer
2100 (Agilent, Palo Alto, CA) according to the manufacturer's
protocols.
Small RNA sequencing
sRNA library preparation and sequencing were performed
with Illumina sequencing technology. The sRNA library was
generated with the TruSeq Small RNA Library Kit. Briefly, 3′
and 5′ adapters were ligated into 1 μg of total RNA with T4
RNA ligase. Then, reverse transcription was performed with
the Illumina sRNA RT-Primer, and cDNA was amplified by
PCR (11 cycles) using the Illumina small RNA primer set.
The amplified total cDNA library was purified and size select-
ed (insert size 22–30 bp) in 6% Novex TBE gel. The tran-
scriptome libraries were sequenced on a HiSeq2500™
(Illumina) with the following parameters: SE50 (single end)
and 10M clean reads, which yielded a minimum of 500Mb of
raw data per sample (SE50, 10 M, 500 Mb). The sRNA-seq
data were submitted to the NCBI Sequence Read Archive
(SRA): SRP150595. The detailed analysis of the regulated
miRNA has been published elsewhere [9]. In this study, we
focus on multiple different classes of sRNAs that are differ-
entially expressed in the blood in response to IA rupture. We
reanalyzed profiles of miRNA regulation to compare and con-
trast with the other classes.
sRNA data analysis
The sequence read quality was evaluated using the FastQC
(0.11.5) quality filter module. The raw reads were mapped
to the reference human genome hg38 using BWA (version
0.7.17). The expression levels were quantified using
IntersectBed (v2.28.0) and GTF with data from the DASHR
database of human small noncoding RNAs in human tissues
and cell types (v2.0). sRNA transcripts with counts per million
(CPM) values above 2 in at least 10 samples were considered
detectable and were used for further analysis.
Identification of differentially expressed sRNA
All statistical analyses were performed using R software
v3.4.3. A normalization step was performed because the total
number of reads from different experiments was not the same,
and variations in the number of reads of individual sRNAmay
be attributable to sequencing depth. The total clone count was
the sum of frequencies of all the residual unique sequences
after filtering. Differential expression was analyzed with the
quasi-likelihood F-test from the edgeR package (v.3.6.8). The
false discovery rate (FDR) was estimated using the
Benjamini-Hochberg method. Sequences with FDR < 0.1
were considered to be differentially expressed. Statistical
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power of the analysis was estimated with two methods: (1)
according to Hart et al. [10] with depth = 676, cv = 0.47 and
was 33.6% for 1.2 fold-change (FC), 85% for 1.5 FC, 97.2%
for 1.7 FC, and 99.86% for 2 FC; (2) by shuffling sRNA
counts, simulating a given FC in a subset of the dataset and
detecting the number of changed sequences that passed the 0.1
FDR. Here, 99.4% of sequences were detected at simulated
1.2 FC in 10% of dataset. Sequences with fold-change > 1.2
compared with controls (C) were considered regulated in par-
ticular conditions. After the fold-change filter was applied,
516 sequences remained.
Conservation analysis
For conservation analysis, phastCons scores for multiple
alignments of 99 vertebrate genomes (list: http://
h g d ow n l o a d . c s e . u c s c . e d u / g o l d e n p a t h / h g 3 8 /
phastCons100way/) to the human genome were averaged
across each sRNA sequence (noncovered bases were given a
score of 0). Conservation scores have values between 0 and 1
(1: means that all bases are conserved in all 100 genomes).
Overrepresentation of ChIP-seq-defined DNA features
To investigate the biological mechanisms involved in the con-
trol of sRNA expression after IA rupture, we searched for
overrepresented transcription factor binding sites on genomic
regions of the regulated transcripts. We employed available
ChIP-seq data (Consortium, 2012) using the online resource
seqinspector (seqinspector.cremag.org). The batch coordinate
conversion (liftOver) was used to convert genome coordinates
between hg38 and hg19 assemblies (516 regulated sRNAs
were converted to 508). The set of genomic coordinates from
sRNA-seq was used as an input. The background reference set
was defined as 455 randomly selected, nonregulated sRNAs
with mean expression levels in the blood similar to those of
the regulated sRNAs. The difference between the query and
reference datasets was calculated by t test with the use of
Bonferroni correction. Where applied, the difference between
class composition was analyzed using the χ2 test.
Results
Alterations in sRNA abundance levels in response to
IA rupture
The study comprised 19 patients in the acute phase of IA
rupture (RAA), 20 patients in the chronic phase of SAH
(RAC), and 20 control subjects (C) (Table 1). The clinical
characteristics of the patients are published elsewhere [4].
We used NGS to comprehensively examine the expression
levels of sRNAs derived from the peripheral blood.
Normalized miRNA abundance levels (CPM) were measured
for the small transcripts annotated in the GRCm38.p13 ge-
nome release. A total of 1766 genes were detected at the
threshold of CPM > 2 in at least 10 samples. To annotate the
genome-mapped sRNA reads, we referred to the UCSC
Genome Browser and Ensembl database. For differential ex-
pression detection, results were considered significant if their
FDR was < 0.01. Comparing RAA, RAC, and controls, we
found 542 differentially expressed sRNAs that included 516
sRNAs with an abundance change of more than 1.2-fold com-
pared with the control. This list of 516 genes was used for
further analysis.
The first goal of the analysis was to investigate classwise
sRNA expression profiles of both the acute and chronic
phases after IA rupture, as well as effects that were sustained
between both timepoints. To identify sRNAs that were specif-
ically regulated at each analyzed timepoint, sRNAs were con-
sidered regulated if they met the fold-change > 1.2 condition
in one or both comparisons (Supplementary Table S1). We
identified 105 sRNAs that were regulated in the acute phase
and 77 sRNAs that were regulated in the chronic phase in
comparison with controls. A total of 286 sRNAs were differ-
entially expressed in both experimental groups compared with
the control, suggesting that most of the investigated sRNAs
underwent prolonged changes in their abundance in blood
after IA rupture (Fig. 1).
To further elucidate sRNA regulation by IA rupture, we
investigated the direction of change of sRNA expression in
the acute and remote SAH period. Among the sRNAs regu-
lated in the acute phase or in both, most (60 downregulated vs.
45 upregulated and 210 downregulated vs. 76 upregulated,
respectively) were downregulated, whereas in the chronic
phase-regulated transcripts, most (42 upregulated vs. 35
downregulated) were upregulated. Eighty-one transcripts
showed a mixed pattern of expression, where 41 were down-
regulated in the acute phase and upregulated in the chronic
phase, while 7 were upregulated in the acute phase and down-
regulated in the chronic phase (Fig. 1, Supplementary
Table S1).
Analysis of class composition of the regulated sRNAs
We next examined the number of regulated sRNAs of each
RNA type. To investigate the specificity of the regulation
patterns described, we compared the abundance of each
sRNA class with a group of randomly selected, nonregulated
sRNAs that included a similar number of sequences as the
largest regulated group (n = 233, Fig. 2, Supplementary
Table S2).
In general, the class composition of nonregulated sRNAs
was clearly distinct from that of downregulated and upregu-
lated sRNAs. Overall, miRNAs, rRNAs, piRNAs, and
scRNAs were the most abundant classes, but their numbers
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differed between experimental groups. In the case of
miRNAs, the number of transcripts was highest within the
nonregulated group (n = 37 vs. n = 3–18 in other groups).
Among the regulated transcripts, sRNAs downregulated in
both SAH phases showed a radically different class composi-
tion compared with all the other groups, with rRNA and
piRNA sequences being overrepresented (rRNA n = 75 vs. n
= 0–23 in other groups, piRNA n = 68 vs. n = 0–31 in other
Fig. 1 Timepoint dependence and direction of sRNA expression changes
after IA rupture. The diagram in the middle represents the number of
small RNAs that were significantly differentially expressed in the tested
conditions. A total of 105 sRNAs were differentially expressed only in
the blood from RAA patients (acute phase, days; blue shape), 77 sRNAs
were differentially expressed only in the blood from RAC patients
(chronic phase, months; pink shape), and 286 sRNAs were changed at
both timepoints. Bar graphs adjacent to each part of the Venn diagram
indicate the direction of sRNA transcript-level changes (blue, percentage
of downregulated transcripts; red, percentage of upregulated transcripts;
green, percentage of transcripts with a mixed expression profile). Small
graphs to the right of each bar illustrate patterns of alterations in
expression
Table 1 Baseline characteristics






Age, years (median, IQR) 54 (48–62) 50 (41–56) 55 (50–60)
Female, % 73.7 90.0 55.0*
Hypertension, % 57.9 55.0 50.0
Smoking, % 31.6 40.0 30.0
Excessive drinking, % 0 5.0 10.0
Diabetes mellitus, % 5.3 5.0 10.0
Hyperlipidemia, % 5.3 0 15.0
Admission Hunt-Hess score (median, IQR) 2 (1–3)
Aneurysms location
Anterior circulation, n 17 16
Posterior circulation, n 2 4
RAA, acute phase of intracranial aneurysm (IA) rupture; RAC, chronic phase of IA rupture; C, control subjects;
IQR, interquartile range; GCS, Glasgow Coma Scale
*p < 0.05 RAC vs. C
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groups). In summary, the class composition analysis showed a
specific pattern of sRNA expression regulation, particularly
among the downregulated transcripts.
Analysis of sequence conservation of the identified
sRNAs
Next, we analyzed how conserved the sequences of the regu-
lated sRNAs are between the human genome and 99 other
vertebrate genomes. To this end, we used available
phastCons scores [11]. First, we investigated whether sRNA
classes are differentially conserved among one another and
between nonregulated and regulated sRNAs. This analysis
was performed by comparing the 516 regulated sRNAs with
a list of 457 nonregulated sRNAs (Supplementary Fig. S1).
This analysis revealed that conservation among sRNA se-
quences is largely class-specific, with tRF3, tRF5, and
scRNAs being the least conserved and tRNAs, piRNAs, and
mir-5p having the highest numbers of conserved sequences.
Out of the highly conserved classes, the piRNAs were over-
represented in the downregulated sRNAs in both the acute and
chronic groups.
Binding patterns of regulatory factors to genomic
positions of regulated sRNAs
We searched for overrepresented transcription factor binding
sites in genomic regions encoding the regulated sRNAs. In
general, sRNA sequences exhibit strong ChIP-seq signals
from multiple transcriptional factors, possibly due to the high
transcriptional activity of these loci.
We compared the lists of upregulated and downregulated
sRNAs in either acute, chronic, or both phases, with a list of
nonregulated sRNAs serving as a reference. The regions ex-
pressing sRNAs downregulated in peripheral blood cells of
patients after IA rupture (both acute and remote period) ex-
hibit a significant overrepresentation of ChIP-seq signals for a
set of transcription factors (TFs) (Supplementary Table S3).
Among these TFs, overrepresentation was detected in more
than one experiment for three factors (Fig. 3a): glucocorticoid
receptor (GR), retinoid x receptor alpha (RXRA), and estro-
gen receptor alpha (ERALPHA). No overrepresentation of TF
binding sites was detected for any other group of regulated
sRNA sequences.
A histogram of GR ChIP-seq average coverage is shown in
Fig. 3b. The peak signal is concentrated near the start of the
Fig. 2 Class composition of the sRNAs regulated in response to
aneurysm rupture. The height of each bar (y-axis) represents the number
of sRNAs, with the bar sections corresponding to the number of sRNAs
in each class. The class name and sRNA number are indicated for classes
with 10 ormoremembers in a given condition. Themost abundant classes
are additionally color-coded: dark blue: piRNA, light blue: primary
miRNA, dark orange: rRNA, light orange: scRNA. Leftmost bar—a set
of nonregulated sRNAs with their class composition. Subsequent bars
show the composition of sRNA classes among the upregulated and down-
regulated transcripts at acute, chronic, and both time points. The right-
most two bars present the class composition of sRNA groups with mixed
expression patterns. Details of numbers of sRNA sequences of each class
and their regulation patterns are available in Supplementary Table S2
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sRNA sequence. An example ChIP-seq signal of an sRNA
(large ribosomal subunit rRNA) with the highest GR signal
is shown in Fig. 3c.
Classwise analysis indicated that the tRNA (particularly
loci with tRNA-His-GTG-1) is the sRNA subtype with
enriched representation of GR-binding in its vicinity (compar-
ison of class composition of sRNAs downregulated in both
phases that have vs. those that do not have GR ChIP-seq
signal coverage, chi-square 59.77, p value < 0.0001). Many
rRNAs (5S, SSU, and LSU) and piRNAs (including piR-
44984, piR-36233, piR-31080, piR-48966, piR-48966, piR-
57947, and piR-36329) also showed GR binding-site
overrepresentation (Fig. 3d). A similar pattern was observed
for the other TFs (Supplementary Fig. S2).
Discussion
To the best of our knowledge, this report is the first to describe
the effects of IA rupture on sRNA expression in peripheral
blood cells. Transcriptome analysis revealed that alterations in
the expression levels of sRNAs were present both in the acute
and remote periods after SAH. Although the direction of ob-
served changes was generally preserved, for a small subset of
Fig. 3 Overrepresentation of
transcription factor (TF) binding
sites in sRNAs downregulated
after IA rupture with glucocorti-
coid receptor (GR) as an example.
a Overrepresentation of TF bind-
ing sites was detected only in the
sRNAs that showed downregula-
tion in both phases. Nonregulated
sRNAs were used as references. b
Histogram of averaged ChIP-seq
signal of downregulated sRNA
sequences for GR (blue line).
Upregulated sRNA sequences
(red line), nonregulated sRNA
sequences (green line, reference),
and a genome background (gray
line) are shown for comparison. c
GR ChIP-seq signal for LSU-
rRNA_Hsa-L12 genome location
is shown as an example. The GR
binding peak corresponds well
with the rRNA sequence. d Class
composition (in percentage) of
downregulated sRNA sequences
with detected representation of
GR binding sites (uppermost
panel, n = 61). This composition
was compared with the class
composition of downregulated
sRNAs without GR binding sites
detected (second panel, n = 149).
Two bottom panels show the class
composition of upregulated and
nonregulated sRNAs. Color-
coding as in Fig. 2, with the
darkest orange added for tRNAs.
The classes with > 20% abun-
dance percentage are indicated
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sRNAs, the directionality differed between phases. Since our
knowledge on the functionality of particular RNA molecules
is notably scarce, interpreting the obtained results remains
difficult. Notably, the downregulated transcripts were pre-
dominantly rRNAs and piRNAs.
At the cellular level, stress leads to alteration of cell metab-
olism and reorganization of nuclear architecture, reflecting the
simultaneous inhibition and activation of specific nuclear
pathways. Since ribosome biosynthesis is a highly energy-
consuming process, one strategy to preserve energy homeo-
stasis is the attenuation of ribosomal biogenesis and rRNA
synthesis. This can be achieved by downregulating rDNA
transcription, pre-RNA processing, and epigenetic regulation
by adjusting the number of active genes. The size of the nu-
cleolus, which plays a crucial role in ribosome biogenesis, is
positively correlated with the rRNA synthesis rate, which de-
pends on cell growth and metabolism [12–14]. Thus, we can
assume that the observed downregulation of rRNA is a re-
sponse of peripheral blood cells to stress caused by IA rupture.
This finding corresponds with lymphopenia present in SAH
patients. Although we observed a simultaneous increase in
monocyte count, considering the absolute numbers of cell
classes, it seems that the drop in lymphocyte count is more
prominent. Moreover, we have previously reported in the
acute phase of SAH a downregulation of HEATR1 (HEAT
repeat-containing protein 1) mRNA. HEATR1 protein is in-
volved in the regulation of ribosomal biogenesis, and its
downregulation causes cell cycle arrest [4].
Another type of downregulated sRNA is piRNAs. These
RNAs are predominantly recognized as molecules responsible
for the regulation of the activity of transposons, which consti-
tute approximately 45% of the human genome. Since transpo-
sons can mobilize in the genome and cause genomic instabil-
ity, piRNAs are recognized as molecules crucial for genome
stability and the prevention of mutagenesis. Moreover,
piRNAs are involved in epigenetic control via DNA methyl-
ation and histone modification [6, 15]. This control was dem-
onstrated not only in germline cells but also in somatic and
cancer cells [16, 17]. The significance of the observed alter-
ations in piRNA expression and their pathophysiological role
after SAH remains to be elucidated. Transposons are implicat-
ed in the immune response in multiple sclerosis and other
autoimmune conditions [18]. Rajan et al. showed altered
piRNA expression in the heart during hypertrophy induction
in a rat model. These researchers also found differences in the
abundance levels of circulating piRNA in the serum of pa-
tients with myocardial infarction, suggesting the importance
of piRNA-mediated mechanisms in various pathophysiologi-
cal conditions affecting the cardiovascular system [19].
Dysregulation of piRNA expression has been shown in many
different human malignancies [20]. Additionally, in a rat ce-
rebral ischemia model, alterations in piRNA expression were
demonstrated in the ischemic cortex [21].
Another interesting observation is differences in conserva-
tion scores among different classes of regulated sRNAs, par-
ticularly the low conservation score of tRFs compared with
the high conservation score of tRNAs. tRNAs together with
rRNAs are housekeeping RNAs. These RNAs are responsible
for the supplying amino acids to ribosomes and other bio-
chemical pathways and regulating cell apoptosis by cyto-
chrome binding, and they are highly conserved in evolution
[22]. Interestingly, the largest tRNA gene cluster is located in
the major histocompatibility complex (MHC) region, which is
crucial in adaptive and innate immunity [23]. tRFs are deri-
vates of tRNAs and are known to accumulate in response to
cellular stress. tRFs play an important regulatory role in gene
expression (at the level of transcription and translation), apo-
ptosis, and cell survival. There is a growing body of evidence
indicating that tRF generation is not a random process, and
their function may vary between cell types [24–26]. For in-
stance, in monocytes, tRF-5030c via PIWI protein interaction
was shown to cause histone H3K9 methylation [27].
Veneziano et al. found significant dysregulation of tRF ex-
pression in human chronic lymphocytic leukemia, suggesting
that this class of molecule could at least serve as a disease
biomarker [28]. Thus, one can speculate that alterations in
tRF expression are specific for the systemic response to SAH.
Analysis of TFBSs among regulated sRNAs revealed sig-
nificant overrepresentation of ChIP-seq signals for a range of
transcription factors. The top 3 overrepresented TFBSs, name-
ly, GR, ERALPHA, and RXRA, belong to the superfamily of
nuclear receptors, and they are all overrepresented among
downregulated sRNA classes.
GR is expressed in nearly all vertebrate cells. GR is in-
volved in the regulation of thousands of genes and participates
in different aspects of development, metabolism, stress re-
sponse, and other processes. GR can interact with DNA di-
rectly or via proteins. Additionally, there are many
coregulators of these interactions, and most GR target genes
are cell type-specific. As a result, the final response to GR
stimulation is context-specific and distinct from the cell type
[29]. Glucocorticoids (GCs) are endogenous agonists of GR.
GCs are known to exert potent regulatory effects on the im-
mune system and inflammatory response. GCs are negative
regulators of thymopoiesis, possess lympholytic properties,
affect T cell activation and polarization (promoting Th2 and
Treg), and influence monocyte function [30, 31]. Increases in
circulating GC levels caused by the activation of the
hypothalamic-pituitary-adrenal axis (HPAA) were shown in
cerebral injuries. A dysregulation of HPAA in SAH patients
with an abnormal diurnal cortisol profile was reported [32,
33]. In an ischemic stroke model, Courties et al. demonstrated
that activation of HPAA with high systemic levels of GCs
affected lymphopoiesis by inducing GR-dependent apoptosis
in thymic T cells and in B-cell progenitors [34]. Similar effects
of traumatic brain injury on T cells were reported [35]. Our
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results suggest that GR may also play a regulatory role by
interacting with some sRNAs.
Additionally, the retinoid X receptor (RXR) plays a role in
the regulation of the immune system. The RXR agonists de-
crease apoptosis of T cells and promote Th2 polarization,
whereas disruption of the RXRA gene in mice resulted in
attenuation of T-cell proliferation and promotion of their ap-
optosis [36]. In addition, disruption of RXR function in mac-
rophages impaired phagocytosis, and RXR activation in-
creased the expression of TGFbeta1 [37]. In rodent models
of SAH and brain ischemia, activation of RXR played a pro-
tective role in damping neuroinflammation [38–40]. In human
carotid atherosclerotic plaques, decreased expression of RXR
in macrophages and smooth muscle cells was associated with
the severity of atherosclerosis [41].
It is widely recognized that estrogen receptors (ERs), in-
cluding ERALPHA, have prominent effects on immune func-
tion in both innate and adaptive immune responses.
ERALPHA is expressed in a variety of immune cells and
plays an important role in the modulation of cytokine produc-
tion, cytokine receptor expression, and the activation of effec-
tor cells. In general, the stimulation of ERALPHA exerts anti-
inflammatory effects. The significance of ERALPHA-
mediated signaling in autoimmune disorders is well recog-
nized [42]. Estrogens are known to play a neuroprotective role
in stroke, primarily attenuating the inflammatory response
[43–45]. The current results indicate that the immunity-
related function of ERALPHA can be mediated by interac-
tions with sRNAs.
Our study has a number of limitations. One limitation is the
limited sample size. However, the numbers of patients investi-
gated here (n = 59) and in other studies focused onmiRNAs are
largely comparable, with other studies including from 24 up to
183 participants [46–49]. Furthermore, presented results have
not been validated in an independent cohort, thus should be
considered proof-of-concept. Further studies are needed to eval-
uate the reproducibility of observed chronic dysregulation of
sRNA levels in IA rupture. Next, the interpretation of the ob-
tained results is speculative to a certain extent. The current
knowledge about the role played by sRNAs in humans remains
highly limited. In addition, transcripts often exist at multiple
less-annotated loci and without full functional description of
the products. Overrepresentation of TFBSs highly transcribed
loci has been previously reported and remains a plausible ex-
planation of the observed phenomenon [50]. Interestingly, a
prominent overrepresentation of GR among TFBSs in regulated
sRNAs corresponds with our understanding of the role played
by GCs in acute stress and immune/inflammatory reactions.
In the light of discussed limitations, presented results
should be considered a proof-of-concept study. Our main ob-
servations are the differences in sRNA expression between the
experimental and control groups and the result that the down-
regulation of many sRNA transcripts persists in the chronic
phase after IA rupture. These should further be validated in a
separate, preferably larger, cohort of patients. If the results are
further validated, there is a translational clinical potential in
the presented observations. Namely, levels of sequences of
various sRNA classes (such as rRNA, tRNA, miRNA) could
serve as potential IA biomarkers; however, further studies are
needed. The interpretation of the observed differences may
change when better genome annotations and functional de-
scriptions of the small RNAs are available.
In conclusion, the results of this study provide novel in-
sights into sRNA regulation in relation to the systemic inflam-
matory response after IA rupture. Specifically, we found that
SAH is associated with the downregulation of sRNAs that are
involved in the regulation of transcription and translation pro-
cesses. These alterations in the expression levels of some
sRNA classes are probably dependent on the activity of the
nuclear receptors GR, ERALPHA, and RXRA.
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